Kandalaft, Lana E. http://orcid.org/0000-0002-1575-6674
Dangaj Laniti, Denarda
Coukos, George http://orcid.org/0000-0001-8813-7367
Article History
Accepted: 28 July 2022
First Online: 15 September 2022
Competing interests
: G.C. declares that he has received grants or research support from or is a co-investigator in clinical trials conducted by Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Iovance, Kite, Roche and Tigen. Lausanne University Hospital has received honoraria for advisory services provided by G.C. to AstraZeneca, Bristol-Myers Squibb, Hoffmann-La Roche, MSD and Geneos Therapeutics. G.C. holds patents related to antibodies and vaccines targeting the tumour vasculature as well as technologies related to T cell expansion and engineering of T cell therapy, for which G.C. receives royalties from the University of Pennsylvania. L.E.K. declares that she has received honoraria for advisory services provided to Geneos Therapeutics and AstraZeneca. D.D.L. declares no competing interests.